About the Authors
Malaria Public Health Cluster, KEMRI-Wellcome Trust–University of Oxford Collaborative Programme, Nairobi, Kenya
Division of Malaria Control, Ministry of Public Health & Sanitation, Nairobi, Kenya
Management for Sciences of Health, Nairobi, Kenya
Medicines for Malaria Venture, Geneva, Switzerland
SMS for Life, Novartis AG, Basel, Switzerland
Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
Center for Global Health and Development, Boston University School of Public Health, Boston, Massachusetts, United States of America
The authors have read the journal's policy and have the following conflicts: the authors confirm that commercial source (Novartis Pharma AG), funded part of the project. They also confirm that JB is an employee of Novartis Pharma AG and that DZ and RWS have received a fee for speaking at a meeting organized by Novartis Pharma AG. Finally, the authors also state that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: SG SK DM AN AMM AW ANM JB GJ DZ. Performed the experiments: SG SK DM AN AMM AW ANM JB DZ. Analyzed the data: SG DZ. Contributed reagents/materials/analysis tools: SG DZ. Wrote the paper: SG SK DM AN AMM AW ANM GJ JB RWS DZ.